You are here

  • Home
  • Archive
  • Volume 8, Issue 11
  • Diagnostic accuracy of imaging brain vesicular monoamine transporter type 2 (VMAT2) in clinically uncertain parkinsonian syndrome (CUPS): a 3-year follow-up study in community patients

Article info

Article menu

Download PDFPDF

XML
Neurology
Research
Diagnostic accuracy of imaging brain vesicular monoamine transporter type 2 (VMAT2) in clinically uncertain parkinsonian syndrome (CUPS): a 3-year follow-up study in community patients

Authors

  • San San Xu Department of Molecular Imaging and Therapy, Austin Health, Melbourne, Victoria, Australia Department of Neurology, Austin Health, Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  • Paschal K Alexander Department of Molecular Imaging and Therapy, Austin Health, Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  • Yenni Lie Department of Molecular Imaging and Therapy, Austin Health, Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  • Vincent Dore Department of Molecular Imaging and Therapy, Austin Health, Melbourne, Victoria, Australia Florey Institute of Neuroscience and Mental Health, University of Melbourne, Melbourne, Victoria, Australia Health & Biosecurity Flagship, The Australian eHealth Research Centre, The Commonwealth Scientific and Industrial Research Organisation, Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  • Svetlana Bozinovski Department of Molecular Imaging and Therapy, Austin Health, Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  • Rachel S Mulligan Department of Molecular Imaging and Therapy, Austin Health, Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  • Kenneth Young Department of Molecular Imaging and Therapy, Austin Health, Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  • Victor L Villemagne Department of Molecular Imaging and Therapy, Austin Health, Melbourne, Victoria, Australia Florey Institute of Neuroscience and Mental Health, University of Melbourne, Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  • Christopher C Rowe Department of Molecular Imaging and Therapy, Austin Health, Melbourne, Victoria, Australia Florey Institute of Neuroscience and Mental Health, University of Melbourne, Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  1. Correspondence to Dr San San Xu; sansan.xu{at}austin.org.au
View Full Text

Citation

Xu SS, Alexander PK, Lie Y, et al
Diagnostic accuracy of imaging brain vesicular monoamine transporter type 2 (VMAT2) in clinically uncertain parkinsonian syndrome (CUPS): a 3-year follow-up study in community patients
BMJ Open 2018;8:e025533. doi: 10.1136/bmjopen-2018-025533

Publication history

  • Received July 21, 2018
  • Revised August 30, 2018
  • Accepted August 31, 2018
  • First published November 15, 2018.
Online issue publication 
November 22, 2022
Previous versions
Review history

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2018. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.